An effective vaccine against Lyme disease.
Crooy
P
P
SB Biologicals, Rixensart, Belgium.
Lobet
Y
Y
D000954:Antigens, Surface / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D001428:Bacterial Vaccines / Q000276:immunology* / Q000627:therapeutic use; D015748:Borrelia burgdorferi Group / Q000166:cytology; D002986:Clinical Trials as Topic; D006801:Humans; D008074:Lipoproteins; D008193:Lyme Disease / Q000382:microbiology / Q000517:prevention & control*; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology* / Q000378:metabolism
D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D008074:Lipoproteins; C072045:OspA protein; D011994:Recombinant Proteins